LEADER 04720namaa2201045uu 4500
001 doab100094
003 oapen
005 20230511
006 m o d
007 cr|mn|---annan
008 230511s2023 xx |||||o ||| 0|eng d
020 |a 9783036572963 
020 |a 9783036572970 
020 |a books978-3-0365-7296-3 
024 7 |a 10.3390/books978-3-0365-7296-3  |2 doi 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a MKG  |2 bicssc 
720 1 |a Maione, Francesco  |4 edt 
720 1 |a Maione, Francesco  |4 oth 
245 0 0 |a Targeting Inflammation and Inflammatory-Related Diseases with Natural Bioactives 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 online resource (166 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |f Unrestricted online access  |2 star 
520 |a Inflammation is a complex biological response to injury as a result of different stimuli such as pathogens, damaged cells, or irritants. Inflammatory injuries induce the release of a variety of systemic mediators, cytokines, and chemokines that orchestrate cellular infiltration, consequentially bringing about the resolution of inflammatory responses and the restoration of tissue integrity. However, persistent inflammatory stimuli or the disregulation of the mechanisms of the resolution phase can lead to chronic inflammation and inflammatory-based diseases. Nowadays, commercially approved anti-inflammatory drugs are represented by nonsteroidal anti-inflammatory drugs (NSAID); glucocorticoids (SAID); and, in some cases, immunosuppressant and/or biological drugs. These agents are effective for the relief of the main inflammatory symptoms. However, they induce severe side effects, and most of them are inadequate for chronic use. Starting from these premises, the demand for new, effective, and safe anti-inflammatory drugs has led research in new therapeutic directions. The recent and emerging scientific community slant is oriented towards natural products/compounds that could represent a boon for the discovery of new active molecules and for the development of new drugs and potentially useful therapeutic agents in different inflammatory-related diseases. We hope that it will stimulate the interest of the scientific community involved in studying the effects of natural and synthetic compounds in different fields of interest such as acute and chronic inflammation, inflammatory pain, inflammation-related diseases (e.g., autoimmune diseases), amongst others. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine and Nursing  |2 bicssc 
650 7 |a Pharmacology  |2 bicssc 
653 |a alginic acid 
653 |a Allium cepa L. 
653 |a anti-inflammation 
653 |a anti-inflammatory activity 
653 |a antihyperlipidemic 
653 |a Asteraceae 
653 |a autophagy 
653 |a baicalin 
653 |a BELFRIT 
653 |a bioaccessibility 
653 |a biological activity 
653 |a Calceolaria 
653 |a calceolarioside A 
653 |a chelation 
653 |a cichoric acid 
653 |a citropten 
653 |a colitis 
653 |a Crepis 
653 |a design 
653 |a design of experiments 
653 |a diabetes mellitus 
653 |a docking 
653 |a Glaesserella parasuis 
653 |a IL-1β 
653 |a immunity 
653 |a infertility 
653 |a inflammation 
653 |a intestinal cell activation 
653 |a JNK signaling pathway 
653 |a LC-MS 
653 |a MAPK 
653 |a mouse paw edema 
653 |a mPGES-1 
653 |a natural compounds 
653 |a natural products 
653 |a NLRP3 
653 |a NMR 
653 |a nociception 
653 |a osteoclastogenesis 
653 |a oxidative stress 
653 |a Padina boryana 
653 |a particulate matter 
653 |a peritoneum 
653 |a phenolic acid 
653 |a phenylpropanoid glycosides 
653 |a piglets 
653 |a Portulaca oleracea 
653 |a quercetin 
653 |a skin 
653 |a sulforaphane 
653 |a T cell activation 
653 |a Th17 
653 |a tight junctions 
793 0 |a DOAB Library. 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/100094  |7 0  |z Open Access: DOAB: description of the publication 
856 4 0 |u https://mdpi.com/books/pdfview/book/7187  |7 0  |z Open Access: DOAB, download the publication